Celsius (NASDAQ:CELH) PT Lowered to $43.00 at Roth Mkm

Celsius (NASDAQ:CELH) had its target price cut by equities researchers at Roth Mkm from $45.00 to $43.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Roth Mkm’s target price indicates a potential upside of 32.19% from the stock’s current price.

CELH has been the subject of a number of other reports. Stifel Nicolaus decreased their price objective on Celsius from $61.00 to $51.00 and set a “buy” rating for the company in a report on Thursday, September 5th. Jefferies Financial Group cut their price target on shares of Celsius from $68.00 to $53.00 and set a “buy” rating on the stock in a research report on Thursday, September 5th. Morgan Stanley reaffirmed an “equal weight” rating and set a $50.00 price target on shares of Celsius in a research report on Tuesday, August 20th. Truist Financial cut their price target on shares of Celsius from $45.00 to $30.00 and set a “hold” rating on the stock in a research report on Friday, September 6th. Finally, B. Riley cut their price target on shares of Celsius from $80.00 to $73.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, Celsius has an average rating of “Moderate Buy” and an average target price of $57.29.

Celsius Stock Up 3.9 %

NASDAQ CELH opened at $32.53 on Friday. The company has a market capitalization of $7.58 billion, a price-to-earnings ratio of 35.75, a PEG ratio of 2.45 and a beta of 1.85. Celsius has a twelve month low of $30.86 and a twelve month high of $99.62. The stock has a fifty day simple moving average of $38.43 and a 200 day simple moving average of $62.00.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. The business had revenue of $402.00 million during the quarter, compared to the consensus estimate of $391.07 million. Celsius had a return on equity of 94.75% and a net margin of 19.58%. Celsius’s quarterly revenue was up 23.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.17 earnings per share. Research analysts expect that Celsius will post 0.82 earnings per share for the current fiscal year.

Insider Transactions at Celsius

In other news, CEO John Fieldly sold 74,847 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the transaction, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Celsius

Several large investors have recently added to or reduced their stakes in CELH. Vanguard Group Inc. lifted its position in Celsius by 183.6% in the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock valued at $749,458,000 after acquiring an additional 8,899,873 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Celsius by 231.2% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after acquiring an additional 2,754,722 shares in the last quarter. Wellington Management Group LLP lifted its position in Celsius by 212.2% in the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after acquiring an additional 2,306,598 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Celsius by 424.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock valued at $152,287,000 after acquiring an additional 2,261,046 shares in the last quarter. Finally, Eagle Asset Management Inc. lifted its position in Celsius by 188.8% in the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock valued at $161,312,000 after acquiring an additional 1,934,400 shares in the last quarter. Institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.